Introduction: Cardiovascular diseases are the leading cause of death globally, responsible for 17.9 million deaths annually. In Mongolia, as of 2023, CVDs account for 43.7% of total mortality. In line with the global trend of integrating traditional medicine into modern healthcare, Mongolia has increased research into natural, plant-based remedies.
This study focuses on evaluating and standardizing selected natural raw materials commonly used in traditional prescriptions for cardiovascular conditions. The goal is to assess their quality, ensure safety, and support their scientific validation for modern clinical use. The findings aim to contribute to the development of effective, evidence based traditional medicines aligned with national health policy priorities. Methods: All of three medicinal plants (Santalum album L., Myristica fragrans Hountt., Choerospondias axillaris Roxb.) used in this study were purchased from the Chinese. The dried raw materials of all selected plants were authenticated and analyzed using the standards outlined in the Pharmacopoeia of the people’s republic of China 2020 and Japanese pharmacopoeia 18^th edition.
The sample solution showed a spot at the level as the standard santalol, with an Rf value of 0.35. The total volatile oil content of the santalol residue was found to be 3.3% The sample solution showed a spot at the level as the standard myristicin, with an Rf value of 0.6±0.0001 The dehydrodiisoeugenol content in Myristica fragrans was determined using High-Performance Liquid Chromatography (HPLC) and the result was /0.17±0.0001/ % The sample solution showed a spot at the level as the standard gallic acid, with an Rf value of 0.7±0.0001 The gallic acid content in Choerospondias axillaris was determined using High-Performance Liquid Chromatography (HPLC) and the result was /0.097±0.0001/%. Conclusion According to our research, all raw materials in the Santalum album, Myristica fragrans, Choerospondias axillaris preparation meet the requirements of the Pharmacopoeia of the People’s of China.